funding

Study underway in Montreal to estimate how many children and teens have been infected with SARS-CoV-2

Today, Canada’s COVID-19 Immunity Task Force (CITF) announces its support for a research project that will estimate how many children and teens in Montreal have been infected with SARS-CoV-2, the virus that causes COVID-19. This $720,000 investment will allow us to better understand how much virus transmission has occurred to children and teens, and [...]

2021-02-26T10:40:25-05:00October 20, 2020|Media Releases|

Investing in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians

Canada's COVID-19 Immunity Task Force (CITF) announces its support for a new SARS-CoV-2 seroprevalence study focused on aging Canadians, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease.  This $4 million investment will be carried out by the Canadian Longitudinal Study on Aging (CLSA), a national platform for research [...]

2021-02-26T10:42:09-05:00October 1, 2020|Media Releases|

COVID-19 Immunity Task Force launches serological study using antenatal samples

This study will analyze blood samples collected for standard testing in pregnancy from expectant women across Canada to help determine the spread of SARS-CoV-2 and when the virus entered Canada Today, Canada's COVID-19 Immunity Task Force (CITF) announces its support for a study of antenatal serum samples (using blood samples from standard tests from expectant women). This $3.1 [...]

2021-02-26T10:43:28-05:00September 17, 2020|Media Releases|
Go to Top